University of Patras
Αντιμετώπιση της πρώιμης (2 ώρες μετά από φόρτιση με 600mg κλοπιδογρέλη) ανεπαρκούς αναστολής των αιμοπεταλίων σε ασθενείς με οξύ έμφραγμα του μυοκαρδίου με ανάσπαση του ST διαστήματος (STEMI)
Abstract
dc:descriptionObjective: There is a paucity of data regarding the early effectiveness of the proposed 600 mg clopidogrel loading dose (LD) on platelet reactivity (PR) in ST elevation myocardial infarction (STEMI) patients. If high on-treatment platelet reactivity (HTPR) is present, prasugrel reloading and subsequent maintenance dose (MD), might offer faster and stronger platelet inhibition than high clopidogrel MD. Methods: In 93 STEMI patients treated by primary percutaneous coronary intervention we assessed PR using the VerifyNow P2Y12 platelet function test, 2 h following 600 mg LD of clopidogrel. All the 60 (64.5 %) patients exhibiting HTPR (defined as PR ≥ 235 P2Y12 reaction units), were randomized to 1 of 2 therapeutic strategies: reloading with prasugrel 60mg/10mg MD or high (150mg) clopidogrel MD. Results: The primary endpoint of PR at 24 h post randomization was lower in the prasugrel compared to the clopidogrel group (51.3, 25.7–77.0 versus 242.4, 215.8–268.9 P2Y12 reaction units, least square estimates, 95 % confidence intervals, p<0.001). PR at 2 h and 5 days post randomization was lower in the prasugrel compared to the clopidogrel group (117.2, 70.9–163.4 and 101.6, 70.1–133.2 least square mean difference, 95 % confidence intervals, p<0.001 for both). At all the time points of PR assessment, HTPR rates were lower in prasugrel than in clopidogrel group. Conclusions: HTPR is commonly observed early post 600mg clopidogrel LD in STEMI patients. In this case, prasugrel 60mg LD/10mg MD provides faster and stronger platelet inhibition than a high clopidogrel MD regimen.
Degree
thesis:*- Grantor dc:publisher
- University of Patras
- Year dc:date
- 2023
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Theodoropoulos, Konstantinos
- Θεοδωρόπουλος, Κωνσταντίνος
Subjects
dc:subject × 14- Οξύ έμφραγμα του μυοκαρδίου
- Αντιαιμοπεταλιακοί παράγοντες
- Κλοπιδογρέλη
- Πρασουγρέλη
- Acute myocardial infarction
- Antiplatelet agents
- Clopidogrel
- Prasugrel
- Κλινική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Καρδιολογία και Καρδιοαγγειακά νοσήματα
- Clinical Medicine
- Medical and Health Sciences
- Cardiology and Cardiovascular Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/55057